KYRNF vs LLY: Which Stock is Better?
Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Eli Lilly & Co in 2026
KYRNF
KYORIN Pharmaceutical Co., Ltd.
$10.31
LLY
Eli Lilly & Co
$927.03
Key Metrics Comparison
| Metric | KYRNF | LLY | Winner |
|---|---|---|---|
| Market Cap | $592.33M | $809.09B | LLY |
| P/E Ratio | 10.11 | 39.32 | KYRNF |
| EPS (TTM) | $1.02 | $22.99 | LLY |
| Revenue Growth | -0.0% | 0.4% | LLY |
| Gross Margin | 45.3% | 83.0% | LLY |
Analyze KYRNF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYRNF or LLY a better investment?
Comparing KYRNF and LLY: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Eli Lilly & Co has $809.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYRNF and LLY?
KYRNF (KYORIN Pharmaceutical Co., Ltd.) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYRNF or LLY?
Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 39.3x).
Which is growing faster: KYRNF or LLY?
LLY has higher revenue growth at 0.4% vs -0.0% for KYRNF.
Which company is more profitable: KYRNF or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 45.3% for KYRNF.
Which is the larger company: KYRNF or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $809.09B compared to $592.33M for KYRNF.
Should I buy KYRNF or LLY in 2026?
Both KYRNF and LLY have investment merit. KYRNF trades at $10.31 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYRNF and LLY stock?
Key differences: Market Cap ($592.33M vs $809.09B), P/E Ratio (10.1x vs 39.3x), Revenue Growth (-0.0% vs 0.4%), Gross Margin (45.3% vs 83.0%).